Production of sulfated proteoglycans by human breast cancer cell lines: Binding to fibroblast growth factor-2

Journal of Cellular Biochemistry

Volumn 64, Issue 4, 1997, Pages 605-617

  Delehedde, Maryse ^a   Deudon, Elisabeth ^b   Boilly, Benoni ^a   Hondermarck, Hubert ^a  

^a UNIV LILLE   (France)

^b INSERM   (France)

Author keywords

breast cancer; chondroitin sulfate; fibroblast growth factor 2; heparan sulfate; proteoglycans; sulfation

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; PROTEOCHONDROITIN SULFATE;

ARTICLE; BREAST CANCER; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; HYDRODYNAMICS; ION EXCHANGE CHROMATOGRAPHY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; SULFATION;

BREAST NEOPLASMS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; PROTEIN BINDING; PROTEOGLYCANS; SULFATES; TUMOR CELLS, CULTURED;

EID: 0031003946     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19970315)64:4<605::AID-JCB9>3.0.CO;2-V     Document Type: Article

References (66)

1. Alini M, Losa G (1991): Partial characterization of proteoglycans isolated from neoplastic and nonneoplastic human breast tissues. Cancer Res 51:1443-1447.
2. Beck JC, Lekutis C, Couchman J, Parry G (1993): Stage-specific remodeling of the mammary gland basement membrane during lactogenic development. Biochem Biophys Res Commun 190:616-623.
3. Brauer PR, Keller KM, Keller JM (1990): Concurrent reduction in the sulfation of heparan sulfate and basement membrane assembly in a cell model system. Development 110:805-813.
4. Caux F, Timar J, Vigny M, Moczar M (1992): Heparan sulfate synthesised by human melanoma cell variants. Cancer J 5:111-117.
5. Chandrasekaran EV, Davidson EA (1979): Glycosaminoglycans of normal and malignant cultured human mammary cells. Cancer Res 39:870-880.
6. Channe-Gowda D, Bhavanandan VP, Davidson EA (1986): Isolation and characterization of proteoglycans secreted by normal and malignant human mammary epithelial cells. J Biol Chem 261:4926-4934.
7. David G, Bernfield M (1982): Defective basal lamina formation by transformed mammary epithelial cells: a reduced effect of collagen on basal lamina (heparan sulfate-rich) proteoglycan degradation. J Cell Physiol 110:56-62.
8. David G, Van Den Berghe H (1983): Transformed mouse mammary epithelial cells synthesise undersulfated basement membrane proteoglycan. J Biol Chem 258:7338-7344.
9. Delehedde M, Boilly B, Hondermarck H (1995): Differential responsiveness of human breast cancer cells to basic fibroblast growth factor. A cell kinetics study. Oncology Res 7:399-405.
10. Emerman JT, Jones N, Fiedler EE (1988): Glycosaminoglycan accumulation by normal and malignant human mammary epithelial cells in primary culture. Biochem Cell Biol 66:309-318.
11. Esko JD, Rostand KS, Weinke JL (1988): Tumor formation dependent on proteoglycan biosynthesis. Science 241: 1092-1096.
12. Fernig DG, Gallagher JT (1994): Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res 5:353-377.
13. Flaumenhaft R, Moscatelli D, Saksela O, Rifkin DB (1989): Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long term stimulation of plasminogen activator production and DNA synthesis. J Cell Physiol 140:75-81.
14. Flaumenhaft R, Moscatelli D, Rifkin DB (1990): Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J Cell Biol 111: 1651-1659.
15. Fransson LA, Sjöberg I (1981): Copolymeric glycosaminoglycans in transformed cells. J Biol Chem 256:13044-13047.
16. Gannoun-Zaki L, Pieri I, Badet J, Moenner M, Barritault D (1991): Internalisation of basic fibroblast growth factor by chinese hamster lung fibroblast cells: involvement of several pathways. Exp Cell Res 197:272-279.
17. Gospodarowicz D, Cheng J (1986): Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128:475-484.
18. Habuchi H, Suzuki S, Saito T, Harada T, Yoshida K, Kimata K (1992): Structure of heparan oligosaccharide that binds to basic fibroblast growth factor. Biochem J 285:805-813.
19. Hondermarck H, Courty J, Ledoux D, Blanckaert V, Barritault D, Boilly B (1990): Evidence of high and low affinity binding sites for basic fibroblast growth factor in mouse placenta. Biochem Biophys Res Commun 169:272-281.
20. Hondermarck H, Deudon E, Boilly B (1992): Embryonic brain-derived heparan sulfate inhibits cellular membrane binding and biological activity of basic fibroblast growth factor. Dev Brain Res 68:247-253.
21. Hovingh P, Piepkorn M, Linker A (1993): Differentially expressed patterns of glycosaminoglycan structure in heparan sulfate proteoglycans and free chains. Eur J Biochem 211:771-779.
22. Iozzo RV (1988): Proteoglycans and neoplasia. Cancer Metastasis Rev 7:39-50.
23. Ishihara M, Tyrrell DJ, Stauber GB, Brown S, Cousens LS, Stack RJ (1993): Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. J Biol Chem 268:4675-4683.
24. Jacquemier J, Adelaide J, Pare P, Penault-Llorca F, Planche J, Delapeyriere O, Birnbaum D (1994): Expression of the FGFR1 gene in human breast-cancer cells. Int J Cancer 59:373-378.
25. Johnston CL, Cox HC, Gomm JJ, Coombes RC (1995): Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus. J Biol Chem 270:30643-30650.
26. Keller KM, Brauer PR, Keller JM (1989): Modulation of cell surface heparan sulfate structure by growth of cells in the presence of chlorate. Biochemistry 28:8100-8107.
27. Kjellen L, Lindahl U (1991): Proteoglycans: Structure and interactions. Ann Rev Biochem 60:443-475.
28. Lapis K, Timar J, Jeney A (1992): Proteoglycans as target in the therapy of metastasis. In Rabes H, Peters PE, Munk K (eds): "Metastasis: Basic Research and Its Clinical Applications." Basel; New York: Karger.
29. Lee EH, Lee WH, Kaetzel CS, Parry G, Bissell MJ (1985): Interaction of mouse mammary epithelial cells with collagen substrata: Regulation of casein gene expression and secretion. Proc Natl Acad Sci USA 82:1419-1423.
30. Leppa S, Mali M, Miettinen HM, Jalkanen M (1992): Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc Natl Acad Sci USA 89:932-936.
31. Losa GA, Alini M (1993): Sulfated proteoglycans in the extracellular matrix of human breast tissues with infiltrating carcinoma. Int J Cancer 54:552-557.
32. Luqmani YA, Graham M, Coombes RC (1992): Expression of basic fibroblast growth factor, FGFR-1 and FGFR-2 in normal and malignant human breast, and comparison with other normal tissues. Br J Cancer 66:273-280.
33. Maccarana M, Casu B, Lindahl U (1993): Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem 268:23898-23905.
34. Mali M, Elenius K, Miettinen HM, Jalkanen M (1993): Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan-1. J Biol Chem 268:24251-24222.
35. Mangakis N, Serht B, Mangakis P, Bowe E, Kleemann I (1990): Determining the degree of malignancy of individual cases of mammary carcinoma on the basis of clinical, morphological and biochemical parameters. Bull Cancer 77:235-242.
36. Moczar M, Caux F, Bailly M, Berthier O, Dore JF (1993) Accumulation of heparan sulfate in the culture of human melanoma cells with different metastatic ability. Clin Exp Metastasis 11:462-471.
37. Olsen EB, Trier K, Eldov K, Ammitzboll T (1988): Glycosaminoglycans in human breast cancer. Acta Obstet Gyneco Scand 67:539-542.
38. Pantaliano MW, Horlick RA, Springer BA, Van Dick DE, Tobery T, Wetmore DR, Lear JD, Nahapetian AT, Bradley JD, Sisk WP (1994): Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 33:10229-10248.
39. Parry G, Lee EYH, Farson D, Koval M, Bissel MJ (1985): Collagenous substrata regulate the nature and distribution of glycosaminoglycans produced by differentiated cultures of mouse mammary epithelial cells. Exp Cell Res 156:487-499.
40. Pejler G, David G (1987): Basement membrane heparan sulfate with high affinity for antithrombin synthesised by normal and transformed mouse mammary epithelial cells. Biochem J 248:69-77.
41. Penault-Llorca F, Bertucci F, Adelaide J, Pare P, Coulier F, Jacquemier J, Birnbaum D, Delapeyriere O (1995): Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer 61:170-176.
42. Peterson OW, Ronnov-Jessen L, Howlett AR, Bissel MJ (1992): Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA 89:9064-9068.
43. Peyrat JP, Hondermarck H, Louchez MM, Boilly B (1991): Demonstration of basic fibroblast growth factor binding sites in human breast cancer cell lines. Cancer Commun 3:323-329.
44. Peyrat JP, Bonneterre J, Hondermarck H, Hecquet B, Adenis A, Louchez MM, Lefebvre J, Boilly B, Demaille A (1992): Basic fibroblast growth factor: mitogenic activity and binding sites in human breast cancer. J Steroid Biochem Biol 43:87-94.
45. Piedagnel R, Prie D, Cassingena R, Ronco PM, Lelongt B (1994): SV40 Large-T oncogene inhibits transcription of perlecan-related proteoglycans but stimulates hyaluronan synthesis in a temperature-sensitive renal tubule principal cell line. J Biol Chem 269:17469-17476.
46. Piepkorn M, Hovingh P, Linker A (1991): Proteoglycan and glycosaminoglycan free chain expression in keratinocytes, endothelium and mesenchymal cells. Biochem Biophys Res Commun 179:1281-1288.
47. Quarto N, Amalric F (1994): Heparan sulfate proteoglycans as transducers of FGF-2 signalling. J Cell Science 107: 3201-3212.
48. Rapraeger A, Bernfield M (1985): Cell surface proteoglycan of mammary epithelial cells. Protease release of heparan sulfate-rich ectodomain from a putative membrane anchored domain. J Biol Chem 260:4103-4109.
49. Rapraeger A, Yeoman C (1989): A quantitative solid-phase assay for identifying radiolabeled glycosaminoglycans in crude cell extracts. Anal Biochem 179:361-365.
50. Robinson J, Viti M, Höök M (1984): Structure and properties of an undersulfated heparan sulfate proteoglycan synthesised by a rat hepatoma cell line. J Cell Biol 98:946-953.
51. Roghani M, Moscatelli D (1992): Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J Biol Chem 267:22156-22162.
52. Roghani M, Mansukhani A, Dell'Era P, Bellosta P, Basilico C, Moscatelli D (1994): Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J Biol Chem 269:3976-3984.
53. Romans M, Villena J, Molist A, Heredia A, Bassols A (1994): Ras transformation alters the composition of extracellular matrix proteoglycans in rat fibroblasts. Biochem Biophys Res Commun 200:925-932.
54. Rusnati M, Urbinati C, Presta M (1993): Internalisation of basic fibroblast growth factor in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors. J Cell Physiol 154:152-161.
55. Saksela O, Moscatelli D, Sommer A, Rifkin DB (1988): Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol 107:743-751.
56. Schmidtchen A, Fransson LA (1994): Analysis of heparan-sulfate chains and oligosaccharides from proliferating and quiescent fibroblasts. A proposed model for endoheparanase activity. Eur J Biochem 223:211-221.
57. Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP (1994): Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 31:325-335.
58. Steinfeld R, Van Den Berghe H, David G (1996): Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol 133:405-416.
59. Takeuchi J, Sobue M, Sato E, Shamoto M, Miura K, Nakagaki S (1976): Variation in glycosaminoglycan components of breast tumors. Cancer Res 36:2133-2139.
60. Timar J, Moczar E, Timar F, Pal K, Kopper L, Lapis K, Jeney A (1987): Comparative study on Lewis lung tumor cell lines with low and high metastatic capacity. II. Cytochemical and biochemical evidence for differences in glycosaminoglycans. Clin Exp Metastasis 5:79-87.
61. Timar J, Diczhazi C, Bartha I, Pogany G, Paku S, Raso E, Tovari J, Ladanyi A, Lapis K, Kopper L, Jeney A (1995): Modulation of heparan sulfate/chondroitin sulfate ratio by glycosaminoglycan biosynthesis inhibitors affects liver metastatic potential of tumor cells. Int J Cancer 62:755-761.
62. Timar J, Kovalszky I (1995): Differential expression of proteoglycans on the cell surface of malignant cells and in the tumor stroma. In Adany R (ed): "Tumor Matrix Biology." Boca Raton, FL: CRC Press.
63. Turnbull JE, Fernig DG, Ke Y, Wilkinson MC, Gallagher JT (1992): Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J Biol Chem 267:10337-10341.
64. Tyrrell DJ, Ishihara M, Rao N, Horne A, Kiefer MC, Stauber GB, Lam LH, Stack RJ (1993): Structure and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factor. J Biol Chem 268:4684-4689.
65. Walker A, Turnbull JE, Gallagher JT (1994): Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. J Biol Chem 269:931-935.
66. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM (1991): Cell surface, heparin like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848.